SCHEMBL7810488

SCHEMBL7810488

COc1ccc(F)c2c1C(=O)c1ccncc1C2=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
ALDH1A1 P00352 3/20 0.51
KDM4E B2RXH2 3/20 0.51
USP2 O75604 2/20 0.51
DUSP3 P51452 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
MAPK1 P28482 4/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
RAB9A P51151 3/20 0.44
NPSR1 Q6W5P4 2/20 0.44
FGB P02675 1/20 0.44
POLB P06746 1/20 0.44
THRB P10828 1/20 0.44
ADORA2A P29274 1/20 0.44
PPARG P37231 1/20 0.44
NCOA2 Q15596 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7810480 1.00 MAPT (0.51) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL5139301 0.86 MAOA (0.59) MAPTALDH1A1KDM4EMAOAMAOB
SCHEMBL29642200 0.86 MAOA (0.59) MAPTALDH1A1KDM4EMAOAMAOB
SCHEMBL7817372 0.79 KMT2A (0.37) MAPTMEN1KMT2AALDH1A1TDP1
SCHEMBL7804670 0.79 KMT2A (0.37) MAPTMEN1KMT2AALDH1A1TDP1
SCHEMBL7813936 0.77 MAOA (0.49) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL7819427 0.77 MAOA (0.49) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL7806728 0.77 CDC25B (0.56) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL7811405 0.75 MAPT (0.46) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL5782137 0.70 CDC25B (0.38) MAPTMEN1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0750619-B1 HETERO-ANNULATED INDAZOLES NOVUSPHARMA SPA (IT) 2001-05-30 EP disclosed
EP-0662076-B1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY UNIV VERMONT (US) 2001-04-11 EP disclosed
US-6034092-A ANTITUMOR, ANTICANCER AGENTS NOVUSPHARMA S.P.A. (IT) 2000-03-07 US disclosed
EP-0876369-A1 2- 2- (2-HYDROXYETHYL)AMINO]ETHYL]-5- 2-METHYLAMINO)ETHYL]AMINO]INDAZOLO 4,3-gh]ISOQUINOLIN-6(2H)-ONE AS ANTITUMOR AGENT BOEHRINGER MANNHEIM ITALIA S.p.A. (IT) 1998-11-11 EP disclosed
WO-1997010245-A1 2-[2-[(2-HYDROXYETHYL)AMINO]ETHYL]-5-[[2-METHYLAMINO)ETHYL]AMINO]INDAZOLO[4,3-gh]ISOQUINOLIN-6(2H)-ONE AS ANTITUMOR AGENT BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1997-03-20 WO disclosed
US-5604246-A HAVING POTENCY AGAINST MULTIDRUG RESISTANT TUMORS BOEHRINGER MANNHEIM ITALIA SPA (IT) 1997-02-18 US disclosed
US-5596097-A ANTITUMOR AGENTS THE UNIVERSITY OF VERMONT (US) 1997-01-21 US disclosed
EP-0750619-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA S.p.A. (IT) 1997-01-02 EP disclosed
US-5519029-A ANTITUMOR AGENTS BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1996-05-21 US disclosed
WO-1995024407-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1995-09-14 WO disclosed
EP-0662076-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1995-07-12 EP disclosed
WO-1994006795-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1994-03-31 WO disclosed